XML for Drug Information

XML and Pharmaceutical Information - A New Approach to Enabling Medicines
Information.

Examines how XML-based standards and technologies help increase the reach
and effectiveness of regulated medicines information (³labelling² -
prescribing information, patient information, and pharmaceutical data) as an
authoritative content source across the pharmaceutical enterprise and into
the day-to-day world of healthcare.

Focuses on how properly structured and coded labelling information can be
used in XML-based clinical decision support systems and, by pharmaceutical
companies, as party of a reference core for safety knowledge management,
risk management, portfolio management and marketed product support systems.
Highlights the link that XML-based standards and systems can forge between
pharmaceutical companies, physicians and patients, and the crucial role that
³labelling² plays. Discusses common trends in XML-based software
development within large pharma and invites dialogue on how to resolve
redundant initiatives.

Learning Objectives
After taking this course you will understand:

- How XML based technologies can improve effectiveness of regulated
medicines information

- How pharmaceutical and clinical content of medicines information can be
made computer processable

- How a labelling-based reference structure can be used as a kernel for a
safety knowledge management system

Who should attend
This course is aimed at decision makers and conceptual thinkers in the
pharmaceutical and medical communities who are wrestling with the
application of new XML-based standards across the enterprise in a cohesive
fashion (SPL, PIM, RCRIM, CDISC, etc.). Limited to 20 delegates.

See http://www.pharmweb.net/conferences.html for further information

	#1
PharmWeb	XML for Drug Information XML and Pharmaceutical Information - A New Approach to Enabling Medicines Information. Examines how XML-based standards and technologies help increase the reach and effectiveness of regulated medicines information (³labelling² - prescribing information, patient information, and pharmaceutical data) as an authoritative content source across the pharmaceutical enterprise and into the day-to-day world of healthcare. Focuses on how properly structured and coded labelling information can be used in XML-based clinical decision support systems and, by pharmaceutical companies, as party of a reference core for safety knowledge management, risk management, portfolio management and marketed product support systems. Highlights the link that XML-based standards and systems can forge between pharmaceutical companies, physicians and patients, and the crucial role that ³labelling² plays. Discusses common trends in XML-based software development within large pharma and invites dialogue on how to resolve redundant initiatives. Learning Objectives After taking this course you will understand: - How XML based technologies can improve effectiveness of regulated medicines information - How pharmaceutical and clinical content of medicines information can be made computer processable - How a labelling-based reference structure can be used as a kernel for a safety knowledge management system Who should attend This course is aimed at decision makers and conceptual thinkers in the pharmaceutical and medical communities who are wrestling with the application of new XML-based standards across the enterprise in a cohesive fashion (SPL, PIM, RCRIM, CDISC, etc.). Limited to 20 delegates. See http://www.pharmweb.net/conferences.html for further information